May 14, 2025
Sanofi to invest at least $20 billion in the US through 2030, growing investments in science and expanding domestic manufacturing
Apr 15, 2025
Chrissy Teigen - author, entrepreneur, mom to young son with type 1 diabetes - joins Sanofi's Screen For Type 1 movement
Mar 14, 2025
Sanofi adopts FDA-selected flu strains to ensure readiness for the 2025-26 flu season
May 10, 2024
Inhibrx, Inc. Announces Updated When-Issued Trading Date for Anticipated Spin-Off
May 10, 2024
Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine and Develop Novel COVID-19-Influenza Combination Vaccines
May 08, 2024
Inhibrx, Inc. Announces Record Date and Expected Distribution Time for Anticipated Spin-Off and the Expected Merger Effective Time for Anticipated Merger
Mar 26, 2024
ReportLinker Reveals Key Insights About Players and Coverage in Latest Combination Vaccine Market Analysis
Jan 23, 2024
Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2B
Feb 22, 2021
FDA Approves Libtayo® (cemiplimab-rwlc) Monotherapy for Patients with First-line Advanced Non-small Cell Lung Cancer with PD-L1 Expression of >=50%
Sep 21, 2020
Late-breaking ESMO Presentation Shows Libtayo® (cemiplimab) Monotherapy Increases Overall Survival in First-line Advanced Non-small Cell Lung Cancer with PD-L1 Expression of >=50%
Sep 18, 2020
Positive Pivotal Data for Libtayo® (cemiplimab) Monotherapy in Locally Advanced Basal Cell Carcinoma Featured as a Late-breaking Presentation at ESMO
Sep 14, 2020
FDA Grants Dupixent® (dupilumab) Breakthrough Therapy Designation for Eosinophilic Esophagitis
Sep 09, 2020
Sanofi Genzyme continues research to improve the lives of patients with multiple sclerosis, with new data presented at MSVirtual2020
Sep 03, 2020
Late-breaking Libtayo® (cemiplimab) Pivotal Data in Advanced Non-small Cell Lung Cancer and Basal Cell Carcinoma to Be Presented at ESMO
Aug 31, 2020
Regulus Therapeutics Announces Restructuring of Sanofi and Oxford Loan Agreements
Aug 17, 2020
Sanofi to acquire Principia Biopharma
Jul 29, 2020
Sanofi H1 2020 business EPS(1) growth of 9.2%(2) driven by transformation
Jul 22, 2020
Sanofi begins shipping flu vaccines in U.S. for 2020-2021 season
Jul 14, 2020
Sanofi and MD Anderson announce strategic collaboration to accelerate oncology research and development
Jul 09, 2020
Kymera Therapeutics And Sanofi Enter Into Strategic Partnership To Advance Novel Protein Degrader Therapies To Patients